Laurion Capital Management LP Royalty Pharma PLC Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $801,152 - $943,964	-21,347 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$39.85 - $46.63 $1.14 Million - $1.34 Million	-28,653 Reduced 57.31%	21,347 $875,000
Q1 2021 May 14, 2021	SELL	$42.34 - $52.82 $338,720 - $422,560	-8,000 Reduced 13.79%	50,000 $2.18 Million
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $288,960 - $400,400	8,000 Added 16.0%	58,000 $2.9 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $2.23 Million - $2.61 Million	50,000 New	50,000 $2.43 Million

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.